- Daily & Weekly newsletters
- Buy & download The Bulletin
- Comment on our articles
Cell therapy developed in wallonia cures leukaemia patient in US
Biotechnology company Celyad, based in Mont-Saint-Guibert in Walloon Brabant, has announced the first successful cure of a leukaemia patient using its patented cell therapy CAR-T.
The therapy was used on a patient suffering from intractable acute myeloid leukaemia (AML), a cancer of the blood.
The patient, treated in the US, had not received chemotherapy before the use of CAR-T therapy.
The patient was one of 14 being treated with CAR-T in a study taking place in the US and Europe.